知臨醫藥業務

知臨集團醫藥業務:正尋求開發多個藥物分子(包括運用天然物質的提煉物或衍生物用於疾病治療)和
相關技術以治療及診斷人類疾病,適應症範圍包括神經內科、傳染病、胃腸病、癌症及其他疾病。

Acticule

Acticule專注於傳染病治療的臨床研發工作,主要研究類別包括可成為口服及注射形式的抗病毒和細菌抗生素的候選藥物。目前,Acticule設立了一所藥物發現中心,配備了全自動化的機械平台進行高通量篩選程序,創建可進行早期及臨床研究的嚴選及通過測試的候選藥物的永續生產管道。

Videns

Videns專注於神經退行性疾病和影像診斷發明的大型戰略臨床研發工作。目前的主要項目包括:(i) 應用於早期診斷認知障礙症的磁共振成像原理的醫學成像技術;(ii) 應用於神經退行性疾病治療的自噬增强的mTOR非依賴性TFEB激活剂;(iii) 應用於診斷認知障礙症的無創視網膜圖像技術。

Claves

Claves專注於腸胃科治療候選藥物的臨床研發工作。正處於研發階段及將會進行研發的潛力候選藥物集中於的腸道菌群衍生代謝物調節,以預防及治療疾病。Claves亦正在探索建設腸道菌群的調節平台,用以孕育各種能微調腸道菌群程度、有廣泛醫療用途的嶄新處方候選藥物。

Scipio

Scipio專注於癌症治療藥物和診斷方法的研發工作。目前主要的項目包括基於喹啉類和食管癌分子腫瘤學的嶄新抗癌藥劑。

Nativus

Nativus專注於天然健康或利用天然成分(例如綠茶、大蒜和山藥)提取物開發的醫藥和補健產品的研發工作。目前,Nativus集中研究女性健康和視力保養,其正在研發的先導候選藥物應用於子宮內膜異位症和由痛經而引起的女性疼痛症狀之治療。

APD

Aptorum Pharmaceutical Development ("APD") 主責自設藥品研發中心的營運,並正進行進一步擴展。APD的主要任務是推進公司旗下項目的臨床前研究,並委任外部獲cGLP, cGMP 及cGCP認證的委託研究機構進行監管機構要求的臨床發展計劃。

×
使用條款

This Website contains information concerning Aptorum Group Limited (“Aptorum Group”) and its affiliates that may be useful to Aptorum Group’s customers, suppliers, employees, directors and shareholders, as well as members of the general public. However, by using this Website you are accepting all of the terms of this disclaimer notice, including exclusions and limitations of liability. If you do not agree with anything in this notice, you should not use this Website.

Aptorum Group does not claim ownership of the materials and product images on the Website that are provided to us by our third party suppliers.

Where our Website contains links to other sites and resources provided by third parties, these links are provided for your information only. We have no control over the contents of those sites or resources, and accept no responsibility for them or for any loss or damage that may arise from your use of them. These links are provided solely as a convenience to you and not as an endorsement by us of the contents on such third party websites.

While reasonable efforts are made to ensure that the contents of this Website are accurate, this Website and its contents are provided on an “as is,” “as available” basis, without warranties of any kind, including any warranty that the Website will be kept up to date, be true and not misleading, or that the Website will always (or ever) be available for use. Aptorum Group and its affiliates disclaim all warranties, express or implied, with respect to the Website and its contents, including, without limitation, any warranties of accuracy, completeness, timeliness, non-infringement, title, merchantability, or fitness for a particular purpose. Because some jurisdictions do not permit the exclusion of certain warranties, these exclusions may not apply to you.

In no event will Aptorum Group or its affiliates be liable for any incidental, indirect, consequential, or special damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of profits, contracts, goodwill, data, information, income, anticipated savings, or business relationships, whether or not Aptorum Group or its affiliates have been advised of the possibility of such damage, arising out of or in connection with the use of this Website or its contents or any other sites linked to this Website.

If you have any concerns about material which appears on our Website, please contact us. We have the right and the ability to remove immediately from our Website any material that is infringing, defamatory, offensive, abusive, harming, deceptive, threatening or otherwise illegal.